摘要
目的对阿昔洛韦用于面神经炎辅助治疗的临床效果进行探究。方法将2012年1月—2014年1月期间在该院进行诊治的56例面神经炎患者随机分为观察组(28例)和对照组(28例),取地塞米松对对照组患者进行治疗,在此基础上另外取阿昔洛韦对观察组患者进行治疗,并对两组患者治疗后的总有效率进行比较。结果经一段时间的治疗后,观察组取得的总有效率(92.86%)明显高于对照组(71.43%),且不良反应发生率(3.57%)明显低于对照组(21.43%),两组差异有统计学意义(P<0.05)。结论对面神经炎患者采用阿昔洛韦进行辅助治疗可在一定程度上促进患者病情康复,且安全性较高,值得推广。
Objective To discuss the clinical effect of acyclovlr in adjunctive treatment of facial neuritis. Methods 56 cases of patients with facial neuritis diagnosed and treated in our hospital from January 2012 to January 2014 were randomly divided into two groups with 28 cases in each, the control group were treated with dexamethasone, the observation group were treated with acyclovir on the basis of the control group, the total effective rates of the two groups after treatment were compared. Results After a period of treatment, the total effective rate in the observation group was obviously higher than that in the eontrol group, （92.86% vs 71.43%）, and the incidence rate of adverse reactions in the observation group was obviously lower than that in the control group, （3.57% vs 21.43%）, and the differences were statistically significant P〈0.05. Conclusion The acyclovir in adjunctive treatment of patients with facial neuritis can promote the recovery of the patient＇s condition to a eertain degree with high security, which is worth promotion.
出处
《中外医疗》
2016年第9期104-105,共2页
China & Foreign Medical Treatment
